Kenya to Roll Out Safer ARV Regimen
July 28, 2010
Kenya will switch its HIV treatment regimens to contain a less toxic combination of drugs in line with World Health Organization (WHO) guidelines, PlusNews reports. Patients will be initiated on the safer drugs "as soon as next month [August]," according to Ibrahim Mohamed, director of Kenya's National AIDS and Sexually transmitted infections Control Programme. "WHO has recommended that [antiretroviral drug] Stavudine be replaced with less toxic drugs such as Tenofovir (TDF) or Zidovudine, better known as AZT. Some of the side-effects of Stavudine include nerve damage and changes in body shape." The article also discusses patients' reaction, one of "cautious excitement," and funding concerns, which Mohamed said will make the roll out gradual: "we expect to phase it [Stavudine] out completely by the end of four to five years" (7/27).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)